EMA will launch a biosimilar-focused
pilot project this month. The Agency
plans to use this pilot to provide biosimilar
developers with recommendations as
to what studies they should be conducting
based on data from the innovator product.
This program is open to all companies
looking for scientific advice on developing
a biosimilar product.